Matches in Wikidata for { <http://www.wikidata.org/entity/Q59334489> ?p ?o ?g. }
Showing items 1 to 44 of
44
with 100 items per page.
- Q59334489 description "artículu científicu" @default.
- Q59334489 description "im November 2018 veröffentlichter wissenschaftlicher Artikel" @default.
- Q59334489 description "wetenschappelijk artikel" @default.
- Q59334489 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q59334489 name "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 name "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 type Item @default.
- Q59334489 label "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 label "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 prefLabel "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 prefLabel "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 P1433 Q59334489-1DFA9765-BE13-4363-B013-73DA11DCF75C @default.
- Q59334489 P1476 Q59334489-A6C20A70-0783-40CE-804E-45977C4ADDF6 @default.
- Q59334489 P2093 Q59334489-267BE5E3-7CE5-438F-BD1A-C21B17A07641 @default.
- Q59334489 P2093 Q59334489-31FF0766-EE53-4BB2-8326-E6953637C65D @default.
- Q59334489 P2093 Q59334489-9EA9A98A-F376-41D6-BA6C-2E8C9385CBCF @default.
- Q59334489 P2093 Q59334489-E094E1D6-B351-4C2B-91BE-0E9444BE36AA @default.
- Q59334489 P275 Q59334489-f1954724-9af5-4676-bfc2-7e81a56a3d5e @default.
- Q59334489 P304 Q59334489-3EB35E48-47A1-4EF7-A1FC-41C1B402C74E @default.
- Q59334489 P31 Q59334489-A99C6802-444C-472C-BD0A-DACD2CF40F05 @default.
- Q59334489 P356 Q59334489-3DA2606A-06BE-429A-AAEC-4949D0762EA8 @default.
- Q59334489 P433 Q59334489-E514834D-49DA-4E31-BFA8-4F61D02D666A @default.
- Q59334489 P478 Q59334489-B1BACB77-E7ED-44AD-976F-809E6DD3505A @default.
- Q59334489 P50 Q59334489-EC29A996-7967-4DD3-9C00-CDE205162A91 @default.
- Q59334489 P577 Q59334489-4BD6B1A9-6D84-4E99-8683-4226DD0875BD @default.
- Q59334489 P6216 Q59334489-cdf3b83d-3815-411d-8bab-408dc9c49eed @default.
- Q59334489 P932 Q59334489-6D4B3B39-7CE5-43DB-AE3A-2F7B5DB96A02 @default.
- Q59334489 P356 OFY210.1582 @default.
- Q59334489 P1433 Q27725953 @default.
- Q59334489 P1476 "1926. Evaluation of Safety and Effectiveness of Continuous Infusion Ceftolozane/Tazobactam as Outpatient Parenteral Antimicrobial Therapy" @default.
- Q59334489 P2093 "Bruce M Jones" @default.
- Q59334489 P2093 "Henry N Young" @default.
- Q59334489 P2093 "Kathryn Huelfer" @default.
- Q59334489 P2093 "Melissa Wynn" @default.
- Q59334489 P275 Q24082749 @default.
- Q59334489 P304 "S554-S555" @default.
- Q59334489 P31 Q13442814 @default.
- Q59334489 P356 "10.1093/OFID/OFY210.1582" @default.
- Q59334489 P433 "Suppl 1" @default.
- Q59334489 P478 "5" @default.
- Q59334489 P50 Q56223860 @default.
- Q59334489 P577 "2018-11-01T00:00:00Z" @default.
- Q59334489 P6216 Q50423863 @default.
- Q59334489 P932 "6252965" @default.